These findings indicate that signaling pathways (MEK 1/2 and Akt) are essential for CXCL12-induced cholangiocarcinoma proliferation and cell invasion, implying a potential role for inhibition of Akt and or MEK signaling cascades in the treatment of biliary cancers. The gene discussed is AKT1; the disease is cholangiocarcinoma.